Management

Chesley's Hypertensive Disorders in Pregnancy

Volumn , Issue , 2009, Pages 389-414

  Leveno, Kenneth J ^a   Cunningham, F Gary ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956060068     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374213-1.00021-5     Document Type: Chapter

References (155)

1. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. Practice Bulletin No. 33, January 2002.
2. National High Blood Pressure Education Program. Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–S22.
3. J.S. Cnossen, H. de Ruyter-Hanhijarvi, J.A. van der Post, B.S. Moi, K.S. Khan and G. Riest (2006) Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review. Acta Obstet Gynecol Scand 85 519-525.
4. M. Knight, On behalf of UKOSS (2007) Eclampsia in the United Kingdom2005. BJOG 114 1072-1078.
5. H.A. Abenhaim, E. Bujold, A. Benjamin and R.A. Kinch (2008) Evaluating the role of bedrest on the prevention of hypertensive disease of pregnancy and growth restriction. Hypertens Pregnancy 27 197-205.
6. S. Meher and L. Duley (2006) Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev. 19 CD005939.
7. J.C. Hauth, F.G. Cunningham and P.J. Whalley (1976) Management of pregnancy-induced hypertension in the nullipara. Obstet Gynecol 48 25.
8. L.C. Gilstrap, F.G. Cunningham and P.J. Whalley (1978) Management of pregnancy-induced hypertension in the nulliparous patient remote from term. Semin Perinatol 2 73.
9. C. Lo, R.S. Taylor, G. Gamble, et al. (2002) Use of automated home blood pressure monitoring in pregnancy: Is it safe? Am J Obstet Gynecol 187 1321.
10. C.R. Barton, J.R. Barton, J.M. O’Brien, N.K. Bergauer and B.M. Sibai (2002) Mild gestational hypertension: Differences in ethnicity are associated with altered outcomes in women who undergo outpatient treatment. Am J Obstet Gynecol 186 896-898.
11. R. Horsager, M. Adams, S. Richey, et al. (1995) Outpatient management of mild pregnancy induced hypertension. Am J Obstet Gynecol 172 383.
12. C.A. Crowther, A.M. Bouwmeester and H.M. Ashurst (1992) Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol 99 13-17.
13. D.A. Turnbull, C. Wilkinson, K. Gerard, et al. (2004) Clinical, psychosocial, and economic effects of antenatal day care for three medical complications of pregnancy: A randomized controlled trial of 395 women. Lancet 363 1104-1109.
14. D.J. Tuffnell, R.J. Lilford, P.C. Buchan, V.M. Prendiville, A.J. Tuffnell, M.P. Holgate and M.D. Jones (1992) Randomized controlled trial of day care for hypertension in pregnancy. Lancet 339 224-227.
15. B.M. Sibai, A.R. Gonzalez, W.C. Mabie, et al. (1987) A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 70 323.
16. B.M. Sibai, J.R. Barton, S. Akl, et al. (1992) A randomized prospective comparison of nifedipine and bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 167 879-885.
17. C.J. Pickles, F. Broughton Pipkin and E.M. Symonds (1992) A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol 99 964-969.
18. D.H. Wide-Swensson, I. Ingemarsson, N.O. Lunnell, et al. (1995) Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: A randomized placebo-controlled study. Am J Obstet Gynecol 173 872-878.
19. P. von Dadelszen, M.P. Ornstein, S.B. Bull, et al. (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis. Lancet 355 87-96.
20. P. von Dadelszen, J. Menzies, S. Gilgoff, F. Xie, M.J. Douglas, D. Sawchuck and L.A. Magee (2007) Evidence-based management for preeclampsia. Front Biosci 12 2876-2889.
21. E. Abalos, L. Duley, D.W. Steyn and D.J. Henderson-Smart (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 24 CD002252.
22. American College of Obstetricians and Gynecologists. Antepartum fetal surveillance. Practice Bulletin No. 9, October 1999.
23. J.M. Alexander, S.L. Bloom, D.D. McIntire, et al. (1999) Severe preeclampsia and the very low-birthweight infant: Is induction of labor harmful? Obstet Gynecol 93 485-495.
24. A.H. Nassar, A.M. Adra, N. Chakhtoura, et al. (1998) Severe preeclampsia remote from term: Labor induction or elective cesarean delivery? Am J Obstet Gynecol 179 1210-1218.
25. B.M. Sibai, M. Taslimi, T.N. Abdella, et al. (1985) Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 152 32-39.
26. B.M. Sibai, B.M. Mercer, E. Schiff, et al. (1994) Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: A randomized controlled trial. Am J Obstet Gynecol 171 818-828.
27. D. Abramovici, S.A. Friedman, B.M. Mercer, et al. (1999) Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: Does the HELLP (hemolysis, elevated liver enzyme, and low platelet count) syndrome matter? Am J Obstet Gynecol 180 221-228.
28. A.G. Witlin, G.R. Saade, F. Mattar, et al. (2000) Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks’ gestation. Am J Obstet Gynecol 182 607-612.
29. B. Haddad, G. Kayem, S. Deis and B.M. Sibai (2007) Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction? Am J Obstet Gynecol 196 237.e1–e5
30. B.M. Sibai and J.R. Barton (2007) Expectant management of severe preeclampsia remote from term: patient selection, management, and delivery indications. Am J Obstet Gynecol 196 514.e1–e9
31. W. Ganzevoort, A. Rep, G.J. Bonsel, W.P. Fetter, L. van Sonderen, J.I. De Vries and H. Wolf PERTA investigators (2005) A randomized controlled trial comparing two temporizing management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. BJOG 112 1337-1338.
32. R.M. Shear, D. Rinfret and L. Leduc (2005) Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction? Am J Obstet Gynecol 192 1119-1125.
33. A.E. Bombrys, J.R. Barton, E.A. Nowacki, M. Habli, L. Pinder, H. How and B.H. Sibai (2008) Expectant management of severe preeclampsia at less than 27 weeks’ gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 199 247.e1–e6
34. D.R. Hall, H.J. Odendaal, D.W. Steyn, et al. (2000) Expectant management of early onset, severe pre-eclampsia: Maternal outcome. Br J Obstet Gynaecol 107 1252-1260.
35. P. Vigil-De Gracia, C. Montufar-Rueda and J. Ruiz (2003) Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks’ gestation. Eur J Obstet Gynecol Reprod Biol 107 24-29.
36. B. Haddad, S. Deis, F. Goffinet, et al. (2004) Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks’ gestation. Am J Obstet Gynecol 190 1590.
37. C. Oettle, D. Hall, A. Roux and D. Grové (2005) Early onset severe pre-eclampsia: expectant management at a secondary hospital in close association with a tertiary institution. BJOG 112 84-88.
38. W. Ganzevoort, A. Rep, J.I. de Vries, G.J. Bonsel and H. Wolf PETRA-investigators (2006) Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders in pregnancy. Am J Obstet Gynecol 195 495-503.
39. M.M.R. Amorim, L.C. Santos and A. Faúndes (1999) Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 180 1283.
40. S.L. Bloom and K.J. Leveno (2003) Corticosteroid use in special circumstances: Preterm ruptured membranes, hypertension, fetal growth restriction, multiple fetuses. Clin Obstet Gynecol 46 150-158.
41. S. Thiagarajah, F.J. Bourgeois, G.M. Harbert, et al. (1984) Thrombocytopenia in preeclampsia: Associated abnormalities and management principles. Am J Obstet Gynecol 150 1-8.
42. J.M. O’Brien, S.A. Shumate, S.L. Satchwell, et al. (2002) Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: Impact on the rate of regional anesthesia. Am J Obstet Gynecol 186 475-483.
43. M.J. Tompkins and S. Thiagarajah (1999) HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: The benefit of corticosteroids. Am J Obstet Gynecol 181 304-309.
44. J.N. Martin Jr., B.D. Thigpen, C.H. Rose, et al. (2003) Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 189 830-839.
45. C.M. Isler, P.S. Barrilleaux, E.F. Magann, et al. (2001) A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 184 1332-1340.
46. J.E. Fonseca, F. Méndez, C. Cataño and F. Arias (2005) Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193 1591-1598.
47. L. Katz, M.M. Ramos de Amorim, J. Natal Figueiroa and J. Luiz Pintoe Silva (2008) Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 198 283.e1–e8
48. G.C. Cunningham and J.A. Pritchard (1984) How should hypertension during pregnancy be managed? Experience at Parkland Memorial Hospital. Med Clin North Am 68 505-526.
49. F. Mattar and B.M. Sibai (2000) Eclampsia: VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 182 307.
50. A.B. Andersgaard, A. Herbst, M. Johansen, et al. (2006) Eclampsia in Scandinavia: Incidence, substandard care, and potentially preventable cases. Acta Obstet Gynecol 85 929-936.
51. M.C. Chames, J.C. Livingston, T.S. Ivester, et al. (2002) Late postpartum eclampsia: A preventable disease? Am J Obstet Gynecol 186 1174-1179.
52. B.M. Sibai (2005) Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 105 402-410.
53. L.C. Chesley (1978) Hypertensive Disorders in Pregnancy. New York: Appleton-Century-Crofts
54. J.A. Pritchard (1955) The use of magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet 100 131-140.
55. J.A. Pritchard and S.A. Pritchard (1975) Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 123 543-552.
56. B.M. Sibai, J.M. Graham and J.H. McCubbin (1984) A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 150 728-733.
57. J.A. Pritchard, F.G. Cunningham and S.A. Pritchard (1983) The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 148 951-961.
58. Royal College of Obstetricians and Gynaecologists. The management of severe pre-eclampsia/eclampsia. Guideline No. 10 (A). London RCOG Press 2006; 1–11.
59. G.R. Thurnau, D.B. Kemp and A. Jarvis (1987) Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: A preliminary report. Am J Obstet Gynecol 157 1435-1442.
60. J. Fong, E.D. Gurewitsch, L. Vipe, et al. (1995) Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia. Obstet Gynecol 85 444-452.
61. M.F. Arango and J.H. Mejia-Mantilla (2006) Magnesium for acute traumatic brain injury. Cochrane Database Syst Rev 18 CD005400.
62. M. Hallak, J.W. Hotca and J.B. Evans (1998) Magnesium sulfate affects the N-methyl-D-aspartate receptor binding in maternal rat brain. Am J Obstet Gynecol 178 S112.
63. K.J. Leveno, J.M. Alexander, D.D. McIntire, et al. (1998) Does magnesium sulfate given for prevention of eclampsia affect the outcome of labor? Am J Obstet Gynecol 178 707-714.
64. M.W. Atkinson, D. Guinn, J. Owen, et al. (1995) Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension. Am J Obstet Gynecol 173 1219.
65. S.E. Szal, M.S. Croughan-Minibane and S.J. Kilpatrick (1999) Effect of magnesium prophylaxis and preeclampsia on the duration of labor. Am J Obstet Gynecol 180 1475.
66. A.G. Witlin, S.A. Friedman and B.A. Sibai (1997) The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: A randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 176 623-631.
67. M.L. Watt-Morse, S.N. Caritis and P.L. Kridgen (1995) Magnesium sulfate is a poor inhibitor of oxytocin-induced contractility in pregnant sheep. J Matern Fetal Med 4 139-148.
68. D.A. Grimes and K. Nanda (2006) Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 108 986-989.
69. M. Hallak, S.M. Berry, F. Madincea, et al. (1993) Fetal serum and amniotic fluid magnesium concentrations with maternal treatment. Obstet Gynecol 81 185-192.
70. F.G. Cunningham and J.A. Pritchard (1984) How should hypertension during pregnancy be managed? Experience at Parkland Memorial Hospital. Med Clin North Am 68 505-514.
71. M. Hallak, J. Martinez-Poyer, M.L. Kruger, et al. (1999) The effect of magnesium sulfate on fetal heart rate parameters: A randomized, placebo-controlled trial. Am J Obstet Gynecol 181 1122.
72. K.B. Nelson and J.K. Grether (1995) Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95 263-272.
73. D.E. Schendel, C.J. Berg, M. Yeargin-Allsopp, et al. (1996) Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low birthweight children aged 3 to 5 years. JAMA 276 1805-1814.
74. C.A. Crowther, J.E. Hilles, L.W. Doyle, et al. (2003) Effect of magnesium sulfate given for neuroprotection before birth: A randomized controlled trial. JAMA 290 2669-2679.
75. S. Marret, L. Marpeau, C. Follet-Bouhamed, et al., le groupe PREMAG (2008) Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil 36 278-288.
76. D.J. Rouse, D.G. Hirtz, E. Thom, et al., For the Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network (2008) A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Eng J Med 359 895-905.
77. Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 345 1455-1463.
78. H.M. Ehrenberg and B.M. Mercer (2006) Abbreviated postpartum magnesium sulphate therapy for women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol 108 833-838.
79. E.B. Taber, L. Tan, C.R. Chao, M.H. Beall and M.G. Ross (2002) Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia. Am J Obstet Gynecol 186 1017-1021.
80. G. Somjen, M. Hilmy and C.R. Stephen (1966) Failure to anesthetize human subjects by intravenous administration of magnesium sulfate. J Pharmacol Exp Ther 154 652-659.
81. J.H. McCubbin, B.M. Sibai, T.N. Abdella, et al. (1981) Cardiopulmonary arrest due to acute maternal hypermagnesemia. Lancet 1 1058-1061.
82. D.B. Cotton, S. Longmire, M.M. Jones, et al. (1986) Cardiovascular alterations in severe pregnancy-induced hypertension: Effects of intravenous nitroglycerin coupled with blood volume expansion. Am J Obstet Gynecol 154 1053-1062.
83. A.K. Bhalla, G.I. Dhall and K. Dhall (1995) A safer and more effective treatment regimen for eclampsia. Aust N Z J Obstet Gynaecol 34 144-148.
84. C. Crowther (1990) Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynaecol 97 110-117.
85. J. Dommisse (1990) Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 97 104-109.
86. S.A. Friedman, K.H. Lim, C.A. Baker and J.T. Repke (1993) Phenytoin versus magnesium sulfate in preeclampsia: a pilot study. Am J Perinatol 10 233-238.
87. Sheehan HL, Lynch JB, eds. Cerebral lesions. In: Pathology of Toxaemia of Pregnancy. Baltimore: Williams & Wilkins; 1973.
88. Williams Obstetrics. 12th ed. New York: Appleton; 1961.
89. L.M. Hellman and J.A. Pritchard (1971) N.J. Eastman, L.M. Hellman (Eds) Williams Obstetrics 14th ed New York (NY): Appleton-Century-Crofts
90. F.G. Cunningham, N.F. Gant and K.J. Leveno (Eds) (2001) Williams Obstetrics 21st ed New York: The McGraw-Hill Companies
91. J.N. Martin, B.D. Thigpen, R.C. Moore, C.H. Rose, J. Cushman and W. May (2005) Stroke and severe preeclampsia and eclampsia: A paradigm shift focusing on systolic blood pressure. Obstet Gynecol 105 246-254.
92. F.G. Cunningham (2005) Severe preeclampsia and eclampsia: systolic hypertension is also important. Obstet Gynecol 105 237-238.
93. B.M. Sibai (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102 181-192.
94. P. Vigil-De Gracia, E. Ruiz, J.C. López, I.A. de Jaramillo, J.C. Vega-Maleck and J. Pinzón (2007) Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Hypertens Pregnancy 26 163-171.
95. W.C. Mabie, A.R. Gonzalez, B.M. Sibai, et al. (1987) A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 70 328-337.
96. S.T. Vermillion, J.A. Scardo, R.B. Newman, et al. (1999) A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 181 858-868.
97. J.A. Scardo, S.T. Vermillion, R.B. Newman, et al. (1999) A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies. Am J Obstet Gynecol 181 862-869.
98. M.A. Belfort, J. Anthony, A. Buccimazza, et al. (1990) Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension. Obstet Gynecol 75 970-977.
99. M.A. Belfort, O. Taskin, A. Buhur, et al. (1996) Intravenous nimodipine in the management of severe preeclampsia: Double blind, randomized, controlled clinical trial. Am J Obstet Gynecol 174 451-462.
100. M. Belfort, J. Anthony, G. Saade, et al. (2003) A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Eng J Med 348 304-311.
101. A.C. Bolte, S. Gafar, J. van Eyck, et al. (1998) Ketanserin, a better option in the treatment of preeclampsia? Am J Obstet Gynecol 178 S118.
102. A.C. Bolte, J. van Eyck, S.F. Gaffar, et al. (2001) Ketanserin for the treatment of preeclampsia. J Perinat Med 29 14.
103. J.R. Wacker, B.K. Wagner, V. Briese, B. Schauf, L. Heilman, C. Bartz and H. Hopff (2006) Antihypertensive therapy in patients with preeclampsia: a randomized multicentre study comparing dihydralazine with urapidil. Eur J Obstet Gynecol Reprod Biol 127 160-165.
104. I. Márquez-Rodas, F. Longo, R.P. Rothlin and G. Balfagón (2006) Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension. J Physiol Biochem 62 45-56.
105. A.Y. Bagrov and J.I. Shapiro (2008) Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol 4 378-392.
106. H.A. Zondervan, J. Oosting, M.E. Smorenberg-Schoorl, et al. (1988) Maternal whole blood viscosity in pregnancy hypertension. Gynecol Obstet Invest 25 83-92.
107. A.C. Sciscione, T. Ivester, M. Largoza, et al. (2003) Acute pulmonary edema in pregnancy. Obstet Gynecol 101 511-518.
108. M. Zinaman, J. Rubin and M.D. Lindheimer (1985) Serial plasma oncotic pressure levels and echoencephalography during and after delivery in severe preeclampsia. Lancet 1 1245-1252.
109. B.M. Sibai, B.C. Mabie, C.J. Harvey, et al. (1987) Pulmonary edema in severe preeclampsia-eclampsia: Analysis of thirty-seven consecutive cases. Am J Obstet Gynecol 156 1174-1185.
110. F.G. Cunningham, J.A. Pritchard, G.D.V. Hankins, et al. (1986) Peripartum heart failure: Idiopathic cardiomyopathy or compounding cardiovascular events? Obstet Gynecol 67 157-168.
111. M.A. Brown, V.C. Zammit and S.A. Lowe (1989) Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci 77 599-608.
112. P. Øian, J.M. Maltau, H. Noddleland, et al. (1986) Transcapillary fluid balance in preeclampsia. Br J Obstet Gynaecol 93 235-242.
113. R.K. Bhatia, S.F. Bottoms, A.A. Saleh, et al. (1987) Mechanisms for reduced colloid osmotic pressure in preeclampsia. Am J Obstet Gynecol 157 106-112.
114. W.M. Gilbert, D.R. Towner, N.T. Field, et al. (2000) The safety and utility of pulmonary artery catheterization in severe preeclampsia and eclampsia. Am J Obstet Gynecol 182 1397.
115. S.L. Clark and D.B. Cotton (1988) Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia. Am J Obstet Gynecol 158 453-461.
116. Hankins GDV, Cunningham FG. Severe preeclampsia and eclampsia: Controversies in management. Williams Obstetrics. 18th ed. (Suppl 12). Norwalk, CT: Appleton & Lange; 1991: 1–12.
117. T.E. Nolan, M.L. Wakefield and L.D. Devoe (1992) Invasive hemodynamic monitoring in obstetrics. A critical review of its indications, benefits, complications, and alternatives. Chest 101 1429-1438.
118. P. Young and R. Johanson (2001) Haemodynamic, invasive and echocardiographic monitoring in the hypertensive parturient. Best Pract Res Clin Obstet Gynaecol 15 605-615.
119. M. López-Llera (1982) Complicated eclampsia: Fifteen years’ experience in a referral medical center. Am J Obstet Gynecol 142 28-39.
120. T.J. Benedetti, R. Kates and V. Williams (1985) Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am J Obstet Gynecol 152 330.
121. W. Ganzevoort, A. Rep, G.J. Bonsel, J.I.P. de Vries and H. Wolf (2004) Plasma volume and blood pressure regulation in hypertensive pregnancy. J Hypertens 22 1235-1242.
122. W. Ganzevoort, A. Rep, G.J. Bonsel, J.I.P. De Vries and H. Wolf (2005) A randomized trial of plasma volume expansion in hypertensive disorders of pregnancy: influence on the pulsatile indices of the fetal umbilical artery and middle cerebral artery. Am J Obstet Gynecol 192 233-239.
123. D. Habek, M.V. Bobic and J.C. Habek (2006) Oncotic therapy in management of preeclampsia. Arch Med Res 37 619-623.
124. M.J. Lucas, K.J. Leveno and F.G. Cunningham (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Eng J Med 333 201-205.
125. E.J. Coetzee, J. Dommisse and J. Anthony (1998) A randomized controlled trial of intravenous magnesium sulfate versus placebo in the management of women with severe preeclampsia. Br J Obstet Gynaecol 105 300-312.
126. Magpie Trial Collaborative Group (2002) Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomized placebo-controlled trial. Lancet 359 1877-1890.
127. M. Miguli and A. Chekairi (2008) Eclampsia, Study of 342 cases. Hypertens Pregnancy 27 103-111.
128. J.M. Schutte, N.W. Schuitemaker, J. van Roosmalen and E.A. Steegers Dutch Maternal Mortality Committee (2008) Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG 115 732-736.
129. O. Basso, S. Rasmussen, C.R. Weinberg, A.J. Wilcox, L.M. Irgens and R. Skjaerven (2006) Trends in fetal and infant survival following preeclampsia. JAMA 296 1357-1362.
130. A.M. Aukes, I. Wessel, A.M. Dubois, J.G. Aarnoudse and G.G. Zeeman (2007) Self-reported cognitive functioning in formerly eclamptic women. Am J Obstet Gynecol 197 365.e1–e6
131. Aukes AM, de Groot JC, Aarnoudse JG, Zeeman GG. Brain lesions several years following eclampsia. Am J Obstet Gynecol. 2009; in press.
132. American College of Obstetricians and Gynecologists. Obstetric analgesia and anesthesia. Practice Bulletin No. 36, July 2002.
133. Zeeman GG, Cunningham FG, Pritchard JA. The magnitude of hemoconcentration with eclampsia. Hypertens Pregnancy 2009; in press.
134. B. Hogg, J.C. Hauth, S.N. Caritis, et al. (1999) Safety of labor epidural anesthesia for women with severe hypertensive disease. Am J Obstet Gynecol 181 1096.
135. D.H. Wallace, K.J. Leveno, F.G. Cunningham, et al. (1995) Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet Gynecol 86 193.
136. B.B. Gutsche and T.G. Cheek (1993) Anesthesia considerations in preeclampsia-eclampsia. S.M. Shnider, G. Levinson (Eds) Anesthesia for Obstetrics 3rd ed Baltimore: Williams & Wilkins 321.
137. N.G. Lavies, B.H. Meiklejohn, A.E. May, et al. (1989) Hypertensive and catecholamine response to tracheal intubation in patients with pregnancy-induced hypertension. Br J Anaesth 63 429-438.
138. J.M. Alexander, D.D. McIntire, K.J. Leveno and F.G. Cunningham (2006) Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet Gynecol 108 826-832.
139. H.S. Chadwick and T. Easterling (1991) Anesthetic concerns in the patient with preeclampsia. Semin Perinatol 15 397-411.
140. R.A. Dyer, I. Els, J. Farbas, et al. (2003) Prospective, randomized trial comparing general with spinal anesthesia for cesarean delivery in preeclamptic patients with a nonreassuring fetal heart trace. Anesthesiology 99 561.
141. R.A. Dyer, J.L. Piercy, A.R. Reed, C.J. Lombard, L.K. Schoeman and M.F. James (2008) Hemodynamic changes associated with spinal anesthesia for cesarean delivery in severe preeclampsia. Anesthesiology 108 802-811.
142. B.B. Head, J. Owen, R.D. Vincent Jr., et al. (2002) A randomized trial of intrapartum analgesia in women with severe preeclampsia. Obstet Gynecol 99 452.
143. M.J. Lucas, S. Sharma, D.D. McIntire, et al. (2001) A randomized trial of the effects of epidural analgesia on pregnancy-induced hypertension. Am J Obstet Gynecol 185 970.
144. L.R. Newsome, R.S. Bramwell and P.E. Curling (1996) Severe preeclampsia: Hemodynamic effects of lumbar epidural anesthesia. Anesth Analg 65 31.
145. S.L. Clark, M.Y. Divon and J.P. Phelan (1985) Preeclampsia/eclampsia: Hemodynamic and neurologic correlations. Obstet Gynecol 66 337-343.
146. D.B. Cotton, M.M. Jones, S. Longmire, et al. (1986) Role of intravenous nitroglycerine in the treatment of severe pregnancy-induced hypertension complicated by pulmonary edema. Am J Obstet Gynecol 154 91-99.
147. P.J. Heller, E.P. Scheider and G.F. Marx (1983) Pharyngo-laryngeal edema as a presenting symptom in preeclampsia. Obstet Gynecol 62 523-532.
148. L.K. Tan and M. deSwiet (2002) The management of postpartum hypertension. BJOG 109 733-736.
149. M.H. Ascarelli, V. Johnson, H. McCreary, J. Cushman, W.L. May and J.N. Martin Jr. (2005) Postpartum preeclampsia management with furosemide: a randomized clinical trial. Obstet Gynecol 105 29-33.
150. J.G. Förster, S. Peltonen, R. Kaaja, et al. (2002) Plasma exchange in severe postpartum HELLP syndrome. Acta Anaesthesiol Scand 46 955-962.
151. B. Obeidat, J. MacDougall and K. Harding (2002) Plasma exchange in a woman with thrombotic thrombocytopenic purpura or severe pre-eclampsia. Br J Obstet Gynaecol 109 961-972.
152. J.S. Dashe, S.M. Ramin and F.G. Cunningham (1998) The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 91 662-671.
153. D.R. Hall, H.J. Odendaal and D.W. Steyn (2001) Expectant management of severe pre-eclampsia in the mid-trimester. Eur J Obstet Gynecol Reprod Biol 96 168-172.
154. I.P. Gaugler-Senden, A.G. Huijssoon, W. Visser, E.A. Steegers and C.J. de Groot (2006) Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks’ gestation: audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol 128 216-221.
155. A. Budden, L. Wilkinson, M.J. Buksh and L. McCowan (2006) Pregnancy outcome in women presenting with pre-eclampsia at less than 25 weeks gestation. Aust N Z J Obstet Gynaecol 46 407-412.